Why This Biotech ETF Keeps Surging | ETF TrendsHere is a new biotech ETF stock that is worth buying, BBP. They seem to be doing well at picking winners. I plan to buy BBP soon even though I already own BIB and XBI. I believe good biotech stocks will outperform the general market easily.
View post –
Why This Biotech ETF Keeps Surging […]
This hollow illusion propagated solely by the fakest of people throwing everything away, is fraying around the riots.All that’s left of this con job is the instant when the herd of dumbfucks realizes they’re just a herd of dumbfucks. Led by much bigger dumbfucks…Value line Geometric w/failed manic overthrow:The real economy is missing in action, which leaves just momentum – […]
Biotech Stocks Could Not Hold the Fort -Global Concerns Mount
Pundits and IT Experts Say Cybersecurity Was Not Breached
We see today that even biotech stocks can sell-off on negative macro sentiment. All of the global news compounded by network issues with United Airlines and the NYSE rattled traders and created a bias toward profit taking. Some market experts say this was more […]
SummaryOvaScience, Sarpeta Therapeutics, Ziopharm Oncology and Keryx Biopharmaceuticals all have a short interest above 20%.
These small cap biotech companies provide attractive characteristics for fundamental weakness through liquidity needs, no revenue and a higher fail rate.
Given these common variables, there is strong indication that a large Marco short strategy has been put in place.
This large short position provides opportunities for contrarian […]
Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]
Not just talking about stocks here. Everything that is usually moving is not and everything that usually doesn’t move has been moving.Bonds: have been volatile, but will decline through the Summer, most likely. Will be highly dependent on “big economic data” because this market is being pseudo-driven by the Fed.Oil: Has been doing nothing for the past 2 months, staying […]
Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of short sellers betting they will collapse in grand fashion. “Of any part of the market, this is the one with the most bubble-like characteristics, without question.”Bubble Watch: Biotech Edition Bubble Watch: Biotech Edition Bubble Watch: Biotech EditionThe financial markets have been on the […]
Avalanche Biotech (NASDAQ:AAVL)Shares of Avalanche Biotech fell as much as 40% in after-hours trading on June 15, 2015 after the company announced results from its phase 2 wet-age related macular degeneration — wet-AMD — trial. The drop is huge but many investors should be assured that the drop was justified because the results were mediocre at best. In addition if […]
“Don’t fight the Fed,” unless The Fed says “sell.” That appears to be the message loud and clear from an absolutely exuberant Biotech bubble that is now up over 75% from Janet Yellen’s “stretched valuations” warning last year…Up almost 90% from post-Yellen dip lows…Yellen’s “irrational exuberance” moment.
Nevertheless, valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms […]
So, today the small caps index (RUT) (IWM) breaks out to all time highs, and the same for the Nasdaq Biotech Index (NBI) (IBB). The S&P Biotech Index ($SPSIBI) (XBI) was already up there. This has the potential to become a melt up, if volume breadth accelerates. …it is all ‘blue sky’.
Jump to original –
small cap stocks and biotech stocks
See which […]
